Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05230693 · ClinicalTrials.gov registry record · NA
SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05230693 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 50 participants.
The verdict
NCT05230693, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Fatigue is a pervasive and disabling symptom in sarcoidosis with limited treatment options. There is a significant association between heightened stress and sarcoidosis-associated fatigue. The proposed project will evaluate the usability/feasibility of a smartphone-based stress management application for the self-management of sarcoidosis-associated stress and fatigue.
Interventions
- BEHAVIORAL Enhanced Standard Care
- BEHAVIORAL Sarcoidosis Patient Assessment and Resource Companion App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-02-23 |
| Est. Completion | 2023-07-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05230693
The ClinicalTrials.gov registry entry for NCT05230693 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Standard Care is the first listed.
NCT05230693 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05230693 about?
NCT05230693 is a clinical study titled "SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue". Fatigue is a pervasive and disabling symptom in sarcoidosis with limited treatment options. There is a significant association between heightened stress and sarcoidosis-associated fatigue. The proposed project will evaluate the usability/feasibility of a smartphone-based stress management applicatio...
What is the current status of trial NCT05230693?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-02-23. Estimated completion is 2023-07-25.
What interventions are being tested in trial NCT05230693?
The interventions under investigation include: Enhanced Standard Care (BEHAVIORAL), Sarcoidosis Patient Assessment and Resource Companion App (BEHAVIORAL).
Who is sponsoring clinical trial NCT05230693?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.